Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00904475 · ClinicalTrials.gov registry record · Phase 4
Pilot Study of the Efficacy and Safety of Lidoderm Patch in the Treatment of Low Back Pain
A Phase 4 study of Chronic Low Back Pain, sponsored by Endo Pharmaceuticals.
- Completed
- Registry status
- Phase 4
- Development phase
- 102
- Enrollment target
- 6
- Study locations
NCT00904475 is a Phase 4 study of Chronic Low Back Pain that has completed, run by Endo Pharmaceuticals. The registered enrollment target is 102 participants, below the 591-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (83% lower). The trial reports 6 study locations across 5 states.
The verdict
NCT00904475, a Phase 4 study of Chronic Low Back Pain, has completed, sponsored by Endo Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 102 participants
- Enrollment target
- 6
- Study locations
Study Summary
Patients with moderate to severe chronic Low Back Pain (LBP) despite current analgesic treatment participated in a Phase IV clinical trial to evaluate the analgesic efficacy of the lidocaine patch 5% compared to placebo in treating moderate to severe chronic LBP.
Conditions Studied
Interventions
- DRUG Lidoderm®
Study Locations (6)
Alabama
- - Birmingham
- - Hueytown
Arizona
- - Phoenix
California
- - Mill Valley
Pennsylvania
- - Allentown
Utah
- - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2003-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00904475
The ClinicalTrials.gov registry entry for NCT00904475 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 591-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (83% lower). The listed sponsor is Endo Pharmaceuticals, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Low Back Pain appearing as the primary indexed condition, and to 1 intervention - of which Lidoderm® is the first listed.
NCT00904475 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Alabama, Arizona, California.
Frequently Asked Questions
What is clinical trial NCT00904475 about?
NCT00904475 is a clinical study titled "Pilot Study of the Efficacy and Safety of Lidoderm Patch in the Treatment of Low Back Pain". Patients with moderate to severe chronic Low Back Pain (LBP) despite current analgesic treatment participated in a Phase IV clinical trial to evaluate the analgesic efficacy of the lidocaine patch 5% compared to placebo in treating moderate to severe chronic LBP.
What is the current status of trial NCT00904475?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 102 participants. The study started on 2003-04.
What conditions does trial NCT00904475 study?
This clinical trial studies the following conditions: Chronic Low Back Pain.
What interventions are being tested in trial NCT00904475?
The interventions under investigation include: Lidoderm® (DRUG).
Who is sponsoring clinical trial NCT00904475?
This trial is sponsored by Endo Pharmaceuticals, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00904475 being conducted?
This trial has 6 study locations across Alabama, Arizona, California, Pennsylvania, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Biofreeze® vs. a Placebo on Chronic Low Back Pain Walking Gait Characteristics and Pain
ACTIVE NOT RECRUITING · Phase 4
-
Determining the Prognostic Value of Continuous Intrathecal Infusion
COMPLETED · Phase 4
-
The Back Pain Consortium Research Program Study
COMPLETED · Phase 4
-
Mobile Neurofeedback for Low Back Pain
RECRUITING · NA
-
Phenotyping Response to Spinal Cord Stimulation in Chronic Low Back Pain
RECRUITING · NA
-
Active Music-Based Intervention in Patients With Chronic Low Back Pain
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.